+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Antibody Fragments Market Size, Share & Trends Analysis Report by Specificity (Monoclonal Antibodies, Polyclonal Antibodies), by Type, by Therapy, by Application, by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 150 Pages
  • August 2022
  • Region: Global
  • Grand View Research
  • ID: 5649391
Description Jump to:
The global antibody fragments market size is expected to reach USD 11.36 billion by 2030, according to this report., expanding at a CAGR of 5.9% from 2022 to 2030. There has been a steady increase in chronic conditions across the globe owing to the increasing geriatric population and societal behavior changes. The expediting urbanization is leading to the growth of the middle class resulting in people adopting a more sedentary and unhealthier lifestyle, in turn, causing an increase in diseases such as diabetes. The emerging markets are predicted to hold the largest patient burden owing to the significant population growth.

Furthermore, growing investments by the key market players have contributed to the industry growth. For instance, in June 2020, Vanderbilt University Medical Center collaborated with AstraZeneca to advance the company’s coronavirus-neutralizing antibodies into clinical development as a possible combination therapy for the treatment and prevention of COVID-19. These factors would drive the market in the coming years.

Antibodies are an important tool for molecular and protein detection. Even though whole antibodies are preferable for most immunoassay applications, the performance for some experiments is only enhanced by antibody fragments, such as F(ab')2 and Fab. Monoclonal antibodies are a significant class of therapeutic drugs that have received approval to treat various cancers. With more than 80 antibodies already approved for use in various disease indications, these antibodies represent the largest class of biopharmaceuticals. The introduction of smaller, antigen-binding antibody fragments has been growing at a fast pace, which is impacting the industry positively.

Antibody fragments are also anticipated to be preferred over full-chain antibodies due to their lower manufacturing and purification costs. The use of antibody fragments for the treatment of a specific disease may be constrained by strict ICD-10 rules. However, the new advancements in the clinical development of antibody fragments for serious diseases may offer significant market growth opportunities.

Antibody Fragments Market Report Highlights

  • By specificity, monoclonal antibodies held the largest share in 2021 as they are considered a significant class of therapeutic agents recommended in the therapy of several forms of malignancies
  • Based on type, the scFv segment is anticipated to witness the fastest growth in the coming years. They provide several advantages such as multivalency, heterologous production, low molecular weight, and multimeric form over the parent mAb
  • By therapy, the monoclonal antibodies segment led the market in 2021. Ranibizumab (Lucentis) captured the largest revenue share in 2021 as these are used for the treatment of visual impairment due to diabetic macular edema, neovascular (wet) age-related macular degeneration (AMD), and others
  • By application, the cancer segment is expected to witness the fastest growth over the forecast period owing to the increasing prevalence of cancer globally, which is resulting in the increasing adoption of antibody fragments for therapeutic purposes
  • North America dominated the market in 2021 owing to the increasing prevalence of immunodeficiency diseases, which has led to the increasing demand for antibody fragments for research purposes
  • Asia Pacific is expected to grow considerably in the future owing to increasing private and public partnership investments in biotech and pharmaceutical research. This has fueled the adoption of antibody fragments


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Competition Milieu
1.3. Segment Outlook
Chapter 2. Research Methodology
2.1. Information Procurement
2.2. Information or Data Analysis
2.3. Market Formulation & Validation
Chapter 3. Antibody Fragments Market Variables, Trends & Scope
3.1. Parent Market Analysis
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of infectious and chronic diseases
3.2.1.2. Antibody fragments are preferred over other alternatives
3.2.1.3. Increasing public-private investments for pharma and biotech research
3.2.2. Market restraint analysis
3.2.2.1. Obstacles in the purification of antibody fragments
Chapter 4. Antibody Fragments Market: Segment Analysis, By Specificity, 2018 - 2030 (USD Million)
4.1. Definitions & Scope
4.2. Global Antibody Fragments Market, By Specificity, 2018 to 2030 (USD Million)
4.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 USD Million
4.3.1. Monoclonal Antibodies
4.3.1.1. Global Antibody Fragments Market, Monoclonal Antibodies, 2018 to 2030 (USD Million)
4.3.2. Polyclonal Antibodies
4.3.2.1. Global Antibody Fragments Market, Monoclonal Antibodies, 2018 to 2030 (USD Million)
Chapter 5. Antibody Fragments Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)
5.1. Definitions & Scope
5.2. Global Antibody Fragments Market, By Type, 2018 to 2030 (USD Million)
5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.3.1. FAB
5.3.1.1. Global Antibody Fragments Market, FAB, 2018 to 2030 (USD Million)
5.3.2. scFv
5.3.2.1. Global Antibody Fragments Market,scFv, 2018 to 2030 (USD Million)
5.3.3. sdAb
5.3.3.1. Global Antibody Fragments Market, sdAb, 2018 to 2030 (USD Million)
5.3.4. Others
5.3.4.1. Global Antibody Fragments Market, others, 2018 to 2030 (USD Million)
Chapter 6. Antibody Fragments Market: Segment Analysis, By Therapy, 2018 - 2030 (USD Million)
6.1. Definitions & Scope
6.2. Global Antibody Fragments Market, By Therapy, 2018 to 2030 (USD Million)
6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
6.3.1. Monoclonal Antibodies
6.3.2. Praxbind (idarucizumab)
6.3.2.1. Global Antibody Fragments Market, Praxbind (idarucizumab), 2018 to 2030 (USD Million)
6.3.3. Ranibizumab (Lucentis)
6.3.3.1. Global Antibody Fragments Market, Ranibizumab (Lucentis), 2018 to 2030 (USD Million)
6.3.4. Certolizumab pegol (Cimzia)
6.3.4.1. Global Antibody Fragments Market, Certolizumab pegol (Cimzia), 2018 to 2030 (USD Million)
6.3.5. Iodine (1311) Metuximab/ Licartin
6.3.5.1. Global Antibody Fragments Market, Iodine (1311) Metuximab/ Licartin, 2018 to 2030 (USD Million)
6.3.6. Beovu (brolucizumab-dbll)
6.3.6.1. Global Antibody Fragments Market, Beovu (brolucizumab-dbll), 2018 to 2030 (USD Million)
6.3.7. Cablivi (caplacizumab-yhdp)
6.3.7.1. Global Antibody Fragments Market, Cablivi (caplacizumab-yhdp), 2018 to 2030 (USD Million)
6.3.8. Blinatumomab/ Blincyto
6.3.8.1. Global Antibody Fragments Market, Blinatumomab/ Blincyto, 2018 to 2030 (USD Million)
6.3.9. PAB
6.3.10. CroFab
6.3.10.1. Global Antibody Fragments Market, CroFab, 2018 to 2030 (USD Million)
6.3.11. Anavip
6.3.11.1. Global Antibody Fragments Market, Anavip, 2018 to 2030 (USD Million)
6.3.12. Anascorp
6.3.12.1. Global Antibody Fragments Market, Anascorp, 2018 to 2030 (USD Million)
6.3.13. Botulism Antitoxin Heptavalent (HBAT)
6.3.13.1. Global Antibody Fragments Market, Botulism Antitoxin Heptavalent (HBAT), 2018 to 2030 (USD Million)
6.3.14. Digibind
6.3.14.1. Global Antibody Fragments Market, Digibind, 2018 to 2030 (USD Million)
6.3.15. DigiFab
6.3.15.1. Global Antibody Fragments Market, DigiFab, 2018 to 2030 (USD Million)
6.3.16. Pipeline
6.3.17. AFM13
6.3.17.1. Global Antibody Fragments Market, AFM13, 2018 to 2030 (USD Million)
6.3.18. HPN-424
6.3.18.1. Global Antibody Fragments Market, HPN-424, 2018 to 2030 (USD Million)
6.3.19. MGD007
6.3.19.1. Global Antibody Fragments Market, MGD007, 2018 to 2030 (USD Million)
6.3.20. Tebotelimab (MGD013)
6.3.20.1. Global Antibody Fragments Market, Tebotelimab (MGD013), 2018 to 2030 (USD Million)
6.3.21. Bentracimab (PB2452)
6.3.21.1. Global Antibody Fragments Market, Bentracimab (PB2452), 2018 to 2030 (USD Million)
6.3.22. Flotetuzumab (MGD006)
6.3.22.1. Global Antibody Fragments Market, Flotetuzumab (MGD006), 2018 to 2030 (USD Million)
6.3.23. AK104
6.3.23.1. Global Antibody Fragments Market, AK104, 2018 to 2030 (USD Million)
6.3.24. Ozoralizumab
6.3.24.1. Global Antibody Fragments Market, Ozoralizumab, 2018 to 2030 (USD Million)
6.3.25. Sonelokimab (ALX0761)
6.3.25.1. Global Antibody Fragments Market, Sonelokimab (ALX0761), 2018 to 2030 (USD Million)
Chapter 7. Antibody Fragments Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)
7.1. Definitions & Scope
7.2. Global Antibody Fragments Market, By Application, 2018 to 2030 (USD Million)
7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 (USD Million)
7.3.1. Cancer
7.3.1.1. Global Antibody Fragments Market, Cancer, 2018 to 2030 (USD Million)
7.3.2. Immunodeficiency
7.3.2.1. Global Antibody Fragments Market, Immunodeficiency, 2018 to 2030 (USD Million)
7.3.3. Others
7.3.3.1. Global Antibody Fragments Market, Others, 2018 to 2030 (USD Million)
Chapter 8. Antibody Fragments Market: Regional Market Analysis, By Region, 2018 - 2030 (USD Million)
8.1. Definitions & Scope
8.2. Regional market share analysis, 2021&2030
8.3. Regional Market Dashboard
8.4. Regional Market: Key Players
8.5. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030
8.6. North America
8.6.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.6.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.6.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.6.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.6.5. U.S.
8.6.5.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.6.5.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.6.5.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.6.5.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.6.6. Canada
8.6.6.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.6.6.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.6.6.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.6.6.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.7. Europe
8.7.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.7.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.7.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.7.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.7.5. Germany
8.7.5.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.7.5.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.7.5.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.7.5.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.7.6. U.K.
8.7.6.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.7.6.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.7.6.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.7.6.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.7.7. France
8.7.7.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.7.7.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.7.7.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.7.7.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.7.8. Italy
8.7.8.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.7.8.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.7.8.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.7.8.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.7.9. Spain
8.7.9.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.7.9.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.7.9.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.7.9.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.7.10. Russia
8.7.10.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.7.10.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.7.10.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.7.10.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.8. Asia Pacific
8.8.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.8.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.8.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.8.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.8.5. China
8.8.5.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.8.5.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.8.5.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.8.5.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.8.6. Japan
8.8.6.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.8.6.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.8.6.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.8.6.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.8.7. India
8.8.7.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.8.7.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.8.7.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.8.7.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.8.8. Australia
8.8.8.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.8.8.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.8.8.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.8.8.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.8.9. South Korea
8.8.9.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.8.9.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.8.9.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.8.9.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.8.10. Singapore
8.8.10.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.8.10.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.8.10.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.8.10.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.9. Latin America
8.9.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.9.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.9.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.9.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.9.5. Mexico
8.9.5.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.9.5.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.9.5.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.9.5.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.9.6. Brazil
8.9.6.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.9.6.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.9.6.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.9.6.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.9.7. Argentina
8.9.7.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.9.7.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.9.7.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.9.7.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.10. Middle East & Africa
8.10.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.10.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.10.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.10.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.10.5. South Africa
8.10.5.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.10.5.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.10.5.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.10.5.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.10.6. Saudi Arabia
8.10.6.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.10.6.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.10.6.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.10.6.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
8.10.7. UAE
8.10.7.1. Market estimates and forecast, by Specificity, 2018 - 2030 (USD Million)
8.10.7.2. Market estimates and forecast, By Type, 2018 - 2030 (USD Million)
8.10.7.3. Market estimates and forecast, by Therapy, 2018 - 2030 (USD Million)
8.10.7.4. Market estimates and forecast, by Application, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Strategy Framework
9.2. Market Participation Categorization
9.3. Company Profile
9.3.1. Pfizer Inc
9.3.1.1. Company Overview
9.3.1.2. Financial Performance
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Sanofi
9.3.2.1. Company Overview
9.3.2.1.1. Albynx
9.3.2.1.1.1. Company Overview
9.3.2.2. Financial Performance
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Novartis AG
9.3.3.1. Company Overview
9.3.3.2. Financial Performance
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. Genentech, Inc.
9.3.4.1. Company Overview
9.3.4.2. Financial Performance
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. AbbVie Inc.
9.3.5.1. Company Overview
9.3.5.2. Financial Performance
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Bristol-Myers Squibb Company
9.3.6.1. Company Overview
9.3.6.2. Financial Performance
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. Johnson & Johnson Services, Inc.
9.3.7.1. Company Overview
9.3.7.2. Financial Performance
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. Lilly
9.3.8.1. Company Overview
9.3.8.2. Financial Performance
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
List of Tables
Table 1 Global Antibody Fragments Market, By Region, 2018 - 2030 (USD Million)
Table 2 Global Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 3 Global Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 4 Global Antibody Fragments Market, By Therapy 2018 - 2030 (USD Million)
Table 5 Global Antibody Fragments Market, By Application 2018 - 2030 (USD Million)
Table 6 North America Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 7 North America Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 8 North America Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 9 North America Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 10 U.S. Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 11 U.S. Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 12 U.S. Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 13 U.S. Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 14 Canada Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 15 Canada Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 16 Canada Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 17 Canada Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 18 Europe Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 19 Europe Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 20 Europe Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 21 Europe Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 22 U.K. Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 23 U.K. Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 24 U.K. Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 25 U.K. Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 26 Germany Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 27 Germany Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 28 Germany Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 29 Germany Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 30 France Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 31 France Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 32 France Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 33 France Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 34 Italy Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 35 Italy Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 36 Italy Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 37 Italy Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 38 Spain Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 39 Spain Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 40 Spain Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 41 Spain Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 42 Russia Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 43 Russia Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 44 Russia Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 46 Russia Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 51 Japan Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 52 Japan Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 53 Japan Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 54 Japan Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 55 China Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 56 China Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 57 China Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 58 China Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 59 India Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 60 India Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 61 India Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 62 India Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 63 Australia Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 64 Australia Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 65 Australia Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 66 Australia Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 67 South Korea Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 68 South Korea Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 69 South Korea Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 70 South Korea Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 71 Singapore Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 72 Singapore Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 73 Singapore Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 74 Singapore Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 75 Latin America Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 76 Latin America Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 77 Latin America Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 78 Latin America Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 79 Brazil Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 80 Brazil Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 81 Brazil Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 82 Brazil Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 83 Mexico Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 84 Mexico Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 85 Mexico Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 86 Mexico Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 87 Argentina Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 88 Argentina Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 89 Argentina Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 90 Argentina Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 91 Middle East & Africa Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 92 Middle East & Africa Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 93 Middle East & Africa Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 94 Middle East & Africa Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 95 South Africa Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 96 South Africa Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 97 South Africa Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 98 South Africa Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 99 Saudi Arabia Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 100 Saudi Arabia Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 101 Saudi Arabia Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 102 Saudi Arabia Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
Table 103 UAE Antibody Fragments Market, By Specificity, 2018 - 2030 (USD Million)
Table 104 UAE Antibody Fragments Market, By Type, 2018 - 2030 (USD Million)
Table 105 UAE Antibody Fragments Market, By Therapy, 2018 - 2030 (USD Million)
Table 106 UAE Antibody Fragments Market, By Application, 2018 - 2030 (USD Million)
List of Figures
FIG. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Antibody fragments market segmentation
Fig. 8 Market driver relevance analysis (Current & future impact)
Fig. 9 Market restraint relevance analysis (Current & future impact)
Fig. 10 Market challenge relevance analysis (Current & future impact)
Fig. 11 Penetration & growth prospect mapping
Fig. 12 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 13 Porter’s Five Forces analysis
Fig. 14 Market penetration vs growth prospect mapping
Fig. 15 Antibody fragments market: Specificity outlook and key takeaways
Fig. 16 Antibody fragments market: Specificity movement analysis
Fig. 17 Monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Polyclonal antibodies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Antibody fragments market: Type outlook and key takeaways
Fig. 20 Antibody fragments market: Type movement analysis
Fig. 21 FAB market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 scFv market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 sdAb market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Antibody fragments market: Therapy outlook and key takeaways
Fig. 26 Antibody fragments market: Therapy movement analysis
Fig. 27 Monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 PAB market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Pipeline market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Antibody fragments market: Application outlook and key takeaways
Fig. 31 Antibody fragments market: Application movement analysis
Fig. 32 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Immunodeficiency market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Regional marketplace: Key takeaways
Fig. 36 Regional outlook, 2021 & 2030
Fig. 37 North America antibody fragments market, 2018 - 2030 (USD Million)
Fig. 38 U.S. antibody fragments market, 2018 - 2030 (USD Million)
Fig. 39 Canada antibody fragments market, 2018 - 2030 (USD Million)
Fig. 40 Europe antibody fragments market, 2018 - 2030 (USD Million)
Fig. 41 U.K. antibody fragments market, 2018 - 2030 (USD Million)
Fig. 42 Germany antibody fragments market, 2018 - 2030 (USD Million)
Fig. 43 Italy antibody fragments market, 2018 - 2030 (USD Million)
Fig. 44 Spain antibody fragments market, 2018 - 2030 (USD Million)
Fig. 45 France antibody fragments market, 2018 - 2030 (USD Million)
Fig. 46 Russia antibody fragments market, 2018 - 2030 (USD Million)
Fig. 47 Asia Pacific antibody fragments market, 2018 - 2030 (USD Million)
Fig. 48 Japan antibody fragments market, 2018 - 2030 (USD Million)
Fig. 49 China antibody fragments market, 2018 - 2030 (USD Million)
Fig. 50 India antibody fragments market, 2018 - 2030 (USD Million)
Fig. 51 Australia antibody fragments market, 2018 - 2030 (USD Million)
Fig. 52 South Korea antibody fragments market, 2018 - 2030 (USD Million)
Fig. 53 Singapore antibody fragments market, 2018 - 2030 (USD Million)
Fig. 54 Latin America antibody fragments market, 2018 - 2030 (USD Million)
Fig. 55 Brazil antibody fragments market, 2018 - 2030 (USD Million)
Fig. 56 Mexico antibody fragments market, 2018 - 2030 (USD Million)
Fig. 57 Argentina antibody fragments market, 2018 - 2030 (USD Million)
Fig. 58 MEA antibody fragments market, 2018 - 2030 (USD Million)
Fig. 59 South Africa antibody fragments market, 2018 - 2030 (USD Million)
Fig. 60 Saudi Arabia antibody fragments market, 2018 - 2030 (USD Million)
Fig. 61 UAE antibody fragments market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Pfizer Inc
  • Sanofi
  • Albynx
  • Novartis AG
  • Genentech, Inc.
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Johnson & Johnson Services, Inc.
  • Lilly

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedAugust 2022
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 7.19 Billion
Forecasted Market Value ( USD ) by 2030 $ 11.36 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Global Antibody Fragments Market by Type (F(ab) Fragments, F(ab')2 Fragments, Single Domain Antibody Fragments (sdAbs)), Antibody Type (Monoclonal, Polyclonal), Application - Forecast 2024-2030 - Product Image

Global Antibody Fragments Market by Type (F(ab) Fragments, F(ab')2 Fragments, Single Domain Antibody Fragments (sdAbs)), Antibody Type (Monoclonal, Polyclonal), Application - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Antibody Fragments Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Image

Antibody Fragments Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • 175 Pages
  • Global
From
Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Drug Type (Monoclonal antibodies, Immunomodulators), By Cancer Type (Lung, Breast), By Service Type, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Cancer Immunotherapy Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Drug Type (Monoclonal antibodies, Immunomodulators), By Cancer Type (Lung, Breast), By Service Type, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 98 Pages
  • Global
From
Antibody Fragments Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Antibody Fragments Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 113 Pages
  • Global
From
Global Combination Antibody Therapy Market by Type (Antibody-Drug Conjugates, Bispecific Antibodies, Chemotherapy-Monoclonal Antibodies), Indication (Cancer, HIV), Route of Administration, Distribution Channel, End-Use - Forecast 2024-2030 - Product Image

Global Combination Antibody Therapy Market by Type (Antibody-Drug Conjugates, Bispecific Antibodies, Chemotherapy-Monoclonal Antibodies), Indication (Cancer, HIV), Route of Administration, Distribution Channel, End-Use - Forecast 2024-2030

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.